2022 annual financial data
Rocket Pharmaceuticals 2022 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -224,343,000 USD and net income was -221,863,000 USD.
Operating cash flow was -178,142,000 USD.
Get free Rocket Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -224,343,000 USD
- Net income
- -221,863,000 USD
- Operating cash flow
- -178,142,000 USD